AN2 Therapeutics Statistics
Total Valuation
ANTX has a market cap or net worth of $192.75 million. The enterprise value is $128.35 million.
Important Dates
The last earnings date was Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ANTX has 37.94 million shares outstanding. The number of shares has increased by 29.10% in one year.
| Current Share Class | 37.94M |
| Shares Outstanding | 37.94M |
| Shares Change (YoY) | +29.10% |
| Shares Change (QoQ) | +3.02% |
| Owned by Insiders (%) | 4.91% |
| Owned by Institutions (%) | 53.87% |
| Float | 22.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.55 |
| P/TBV Ratio | 2.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.48, with zero debt.
| Current Ratio | 10.48 |
| Quick Ratio | 10.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.34% and return on invested capital (ROIC) is -34.44%.
| Return on Equity (ROE) | -51.34% |
| Return on Assets (ROA) | -46.76% |
| Return on Invested Capital (ROIC) | -34.44% |
| Return on Capital Employed (ROCE) | -49.47% |
| Weighted Average Cost of Capital (WACC) | -0.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.66M |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +370.37% in the last 52 weeks. The beta is -0.94, so ANTX's price volatility has been lower than the market average.
| Beta (5Y) | -0.94 |
| 52-Week Price Change | +370.37% |
| 50-Day Moving Average | 4.51 |
| 200-Day Moving Average | 4.32 |
| Relative Strength Index (RSI) | 61.92 |
| Average Volume (20 Days) | 339,212 |
Short Selling Information
The latest short interest is 2.44 million, so 6.43% of the outstanding shares have been sold short.
| Short Interest | 2.44M |
| Short Previous Month | 2.89M |
| Short % of Shares Out | 6.43% |
| Short % of Float | 10.93% |
| Short Ratio (days to cover) | 7.47 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -37.44M |
| Pretax Income | -34.88M |
| Net Income | -34.88M |
| EBITDA | n/a |
| EBIT | -37.44M |
| Earnings Per Share (EPS) | -$0.90 |
Full Income Statement Balance Sheet
The company has $64.40 million in cash and no debt, with a net cash position of $64.40 million or $1.70 per share.
| Cash & Cash Equivalents | 64.40M |
| Total Debt | n/a |
| Net Cash | 64.40M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 75.51M |
| Book Value Per Share | 1.99 |
| Working Capital | 59.49M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -30.41M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -30.41M |
| FCF Per Share | -$0.80 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -29.10% |
| Shareholder Yield | n/a |
| Earnings Yield | -17.67% |
| FCF Yield | -15.78% |
Analyst Forecast
The average price target for ANTX is $9.00, which is 77.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 77.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |